Incheon, South Korea

Secheon Jung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gwangju Institute of Science and Technology. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Secheon Jung. Retrieved from https://idiyas.com/inventor/secheon-jung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Secheon Jung: Innovator in Uric Acid Decomposition

Introduction

Secheon Jung is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the area of uric acid decomposition. His innovative work has the potential to impact medical treatments related to uric acid levels in the body.

Latest Patents

Secheon Jung holds a patent for a "Composition for uric acid decomposition using gold nanoparticles." This composition is characterized by the inclusion of urate oxidase (UOX), gold nanoparticles, and a buffer. The use of gold nanoparticles in this composition represents a novel approach to enhancing the efficiency of uric acid decomposition.

Career Highlights

Secheon Jung is affiliated with the Gwangju Institute of Science and Technology, where he conducts research and development in his field. His work has garnered attention for its innovative approach and potential applications in medical science.

Collaborations

Secheon Jung collaborates with Inchan Kwon, contributing to advancements in their shared research interests. Their partnership exemplifies the collaborative spirit often found in scientific research.

Conclusion

Secheon Jung's contributions to the field of uric acid decomposition through his innovative patent highlight his role as a significant inventor. His work not only showcases his expertise but also opens new avenues for medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…